Trials / Completed
CompletedNCT00566423
Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)
Biomarkers in the Diagnosis and Assessment of PAH
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that baseline plasma brain natriuretic peptide (BNP) and migration inhibitory factor (MIF) levels are surrogate markers of clinical severity of PAH and that changes in plasma brain natriuretic peptide (BNP) and MIF levels pre and post exercise.
Detailed description
As above
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood draw | Venous and Arterial Blood draw samples; 6 Minute Walk test |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-05-01
- Completion
- 2010-06-01
- First posted
- 2007-12-03
- Last updated
- 2011-06-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00566423. Inclusion in this directory is not an endorsement.